AM
Ami Mihir Shah
About Ami Mihir Shah
Ami Mihir Shah has 23 years in corporate governance. Holds Designated Partner and Director roles. Currently with 4 companies, including Naxpar Int Llp and Naxpar Medicamentos Llp. Formerly with 1 company, such as Ciaa'b' Biotech Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Naxpar Int Llp
AAX-6654
|
Designated Partner | 06 Jul 2021 | 2021 | Active |
|
Naxpar Medicamentos Llp
AAF-6828
|
Designated Partner | 16 Mar 2018 | 2016 | Active |
Parnax Lab Limited
L36912MH1982PLC027925
|
Director | 31 Mar 2015 | 1982 | Active |
Naxpar Health Concepts Private Limited
U24230MH2004PTC146642
|
Director | 21 Dec 2020 | 2004 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Ciaa'b' Biotech Limited
U24233MH2003PLC138673
|
Director | 14 Jan 2003 | 2003 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ami Mihir Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ami Mihir Shah
Ami Mihir Shah has 23 years in corporate governance. Holds Designated Partner and Director roles. Currently with 4 companies, including Naxpar Int Llp and Naxpar Medicamentos Llp. Formerly with 1 company, such as Ciaa'b' Biotech Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Ami Mihir Shah is associated with 4 companies as Designated Partner and Director.
Ami Mihir Shah has expertise in General Business, Healthcare and other sectors.
Ami Mihir Shah has 23 years in corporate governance.